Paulo Mora

Olaparib Versus Nonplatinum Chemotherapy in Patients With Platinum-Sensitive Relapsed Ovarian Cancer and a Germline BRCA1/2 Mutation (SOLO3): A Randomized Phase III Trial

Richard T. Penson, Ricardo Villalobos-Valencia, David Cibula et al. · Journal of Clinical Oncology · 2020 · 295 citations · Full text

Medicine, Oncology, Pharmacology +16

Final overall survival results from SOLO3: Phase III trial assessing olaparib monotherapy versus non-platinum chemotherapy in heavily pretreated patients with germline BRCA1 - and/or BRCA2-mutated platinum-sensitive relapsed ovarian cancer (026)

Richard T. Penson, Ricardo Villalobos-Valencia, Nicoletta Colombo et al. · Gynecologic Oncology · 2022 · 34 citations

Medicine, Oncology, Pharmacotherapy +15

Cemiplimab in recurrent cervical cancer: Final analysis of overall survival in the phase III EMPOWER-Cervical 1/GOG-3016/ENGOT-cx9 trial

Ana Oaknin, Bradley J. Monk, Andréia Cristina de Melo et al. · European Journal of Cancer · 2025 · 19 citations

Medicine, Gynecology, Oncology +11

Upswing and expansion of the southern king crab (Lithodes santolla) fishery in Northwest Patagonia: Drivers, trends and opportunities for management

Carlos Molinet, Andrés Olguín, Paulina Gebauer et al. · Regional Studies in Marine Science · 2020 · 17 citations

Natural Resources, Fisheries, Marine Sciences +16

A new passive collector to assess settlement rates, substrate selection and predation pressure in decapod crustacean larvae

Luis Miguel Pardo, Carlos Simón Cardyn, Paulo Mora et al. · Journal of Experimental Marine Biology and Ecology · 2010 · 13 citations · Full text

Life Sciences, Ecology, Zoology +14